Trial Profile
Search for the ocular surface biomarker in the Sjogren's syndrome dry eye patients treated with rebamipide ophthalmic solution.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes; Sjogren's syndrome
- Focus Therapeutic Use
- 20 Nov 2018 Status changed from not yet recruiting to completed.
- 22 May 2015 New trial record